Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Patients with active cancer, certain bleeding disorders, pregnancy, or untreated systemic conditions are not candidates regardless of how strong the recovery interest is
While some people may be good candidates for self-administered injections, working with an expert injector ensures safety, precision, and maximum effectiveness
How it helps disc herniation specifically: Upregulates tendon-related growth factors BPC-157 activates the Egr-1 transcription factor, which drives collagen synthesis in fibrous tissue including the annulus fibrosus Promotes angiogenesis increases VEGF expression, improving blood supply to the avascular disc environment Neuroprotective effects multiple rodent studies show BPC-157 accelerates peripheral nerve regeneration and protects against nerve compression injury Systemic anti-inflammatory suppresses pro-inflammatory cytokine cascades without the immunosuppressive side effects of steroids Protocol: Dose: 250500mcg/day subcutaneous injection Injection site: Lower abdomen or closest accessible subQ site to the injury (though systemic distribution means proximity matters less than for localized joint issues) Duration: 68 weeks loading phase, reassess at week 8 Most people notice reduced nerve pain and improved mobility within 24 weeks
Comparing the Two: A Side-by-Side Summary Which Form Is Right for You
US$ 24.55
US$ 20.67
US$ 27.47
US$ 26.60
US$ 20.78
US$ 22.73
US$ 25.18
